Oscar Health (NYSE:OSCR) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded shares of Oscar Health (NYSE:OSCR - Free Report) from a hold rating to a buy rating in a research report report published on Saturday morning.

Separately, Wells Fargo & Company cut shares of Oscar Health from an "overweight" rating to an "equal weight" rating and cut their price target for the stock from $20.00 to $16.00 in a report on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $18.50.

Oscar Health Stock Performance

Shares of NYSE OSCR traded down $0.13 during mid-day trading on Friday, hitting $14.12. 8,375,870 shares of the company were exchanged, compared to its average volume of 4,488,081. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The stock has a 50 day simple moving average of $13.78 and a 200-day simple moving average of $14.58. Oscar Health has a 1-year low of $11.20 and a 1-year high of $23.79. The firm has a market cap of $3.60 billion, a price-to-earnings ratio of -705.65 and a beta of 1.73.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.83 by $0.09. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The company had revenue of $3 billion for the quarter, compared to analysts' expectations of $2.87 billion. During the same period in the previous year, the company posted $0.62 EPS. Oscar Health's revenue was up 42.2% compared to the same quarter last year. On average, sell-side analysts forecast that Oscar Health will post 0.69 EPS for the current fiscal year.

Insider Activity

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of the firm's stock in a transaction on Monday, May 12th. The stock was sold at an average price of $16.43, for a total value of $410,750.00. Following the completion of the transaction, the director now owns 64,512 shares in the company, valued at $1,059,932.16. This trade represents a 27.93% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 24.39% of the company's stock.

Institutional Investors Weigh In On Oscar Health

A number of large investors have recently added to or reduced their stakes in OSCR. JPMorgan Chase & Co. raised its position in Oscar Health by 348.7% during the fourth quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock worth $139,246,000 after acquiring an additional 8,051,379 shares during the last quarter. BIT Capital GmbH increased its stake in shares of Oscar Health by 5,711.6% during the 4th quarter. BIT Capital GmbH now owns 4,473,853 shares of the company's stock worth $60,129,000 after purchasing an additional 4,396,872 shares in the last quarter. Deerfield Management Company L.P. Series C raised its position in shares of Oscar Health by 50.7% during the 4th quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company's stock worth $159,062,000 after purchasing an additional 3,983,325 shares during the last quarter. Nuveen LLC purchased a new stake in Oscar Health in the 1st quarter valued at approximately $29,684,000. Finally, Gilder Gagnon Howe & Co. LLC grew its holdings in Oscar Health by 51.4% during the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company's stock valued at $85,154,000 after buying an additional 2,151,256 shares during the last quarter. 75.70% of the stock is owned by institutional investors and hedge funds.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.